Anti-ZNF717 monoclonal antibody

Pre-made anti-ZNF717 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ZNF717/ZNF717 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2844-Ab-1/ GM-Tg-hg-IP2844-Ab-2Anti-Human ZNF717 monoclonal antibodyHuman
GM-Tg-rg-IP2844-Ab-1/ GM-Tg-rg-IP2844-Ab-2Anti-Rat ZNF717 monoclonal antibodyRat
GM-Tg-mg-IP2844-Ab-1/ GM-Tg-mg-IP2844-Ab-2Anti-Mouse ZNF717 monoclonal antibodyMouse
GM-Tg-cynog-IP2844-Ab-1/ GM-Tg-cynog-IP2844-Ab-2Anti-Cynomolgus/ Rhesus macaque ZNF717 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2844-Ab-1/ GM-Tg-felg-IP2844-Ab-2Anti-Feline ZNF717 monoclonal antibodyFeline
GM-Tg-cang-IP2844-Ab-1/ GM-Tg-cang-IP2844-Ab-2Anti-Canine ZNF717 monoclonal antibodyCanine
GM-Tg-bovg-IP2844-Ab-1/ GM-Tg-bovg-IP2844-Ab-2Anti-Bovine ZNF717 monoclonal antibodyBovine
GM-Tg-equg-IP2844-Ab-1/ GM-Tg-equg-IP2844-Ab-2Anti-Equine ZNF717 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2844-Ab-1/ GM-Tg-hg-IP2844-Ab-2; GM-Tg-rg-IP2844-Ab-1/ GM-Tg-rg-IP2844-Ab-2;
GM-Tg-mg-IP2844-Ab-1/ GM-Tg-mg-IP2844-Ab-2; GM-Tg-cynog-IP2844-Ab-1/ GM-Tg-cynog-IP2844-Ab-2;
GM-Tg-felg-IP2844-Ab-1/ GM-Tg-felg-IP2844-Ab-2; GM-Tg-cang-IP2844-Ab-1/ GM-Tg-cang-IP2844-Ab-2;
GM-Tg-bovg-IP2844-Ab-1/ GM-Tg-bovg-IP2844-Ab-2; GM-Tg-equg-IP2844-Ab-1/ GM-Tg-equg-IP2844-Ab-2
Products NameAnti-ZNF717 monoclonal antibody
Formatmab
Target NameZNF717
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ZNF717 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2844-Ag-1Recombinant multi-species ZN717/ ZNF717/ X17 protein


    Target information

    Target IDGM-IP2844
    Target NameZNF717
    Gene ID100131827
    Gene Symbol and SynonymsOB1,X17,ZNF717,ZNF838
    Uniprot AccessionQ9BY31
    Uniprot Entry NameZN717_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000227124
    Target ClassificationN/A

    The target: ZNF717, gene name: ZNF717, also named as X17, ZNF838. This gene encodes a Kruppel-associated box (KRAB) zinc-finger protein, which belongs to a large group of transcriptional regulators in mammals. These proteins bind nucleic acids and play important roles in various cellular functions, including cell proliferation, differentiation and apoptosis, and in regulating viral replication and transcription. A pseudogene of this gene was identified on chromosome 1. [provided by RefSeq, May 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.